Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martial Hamon

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
The American Journal of Cardiology|November 10, 2010
Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study)Marie Fertin, Bernadette Hennache, Martial Hamon, et al.
Circulation. Cardiovascular Interventions|February 2, 2010
Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialTimothy A Sanborn, Ramin Ebrahimi, Steven V Manoukian, et al.
Clinical Cardiology|October 12, 2013
Comparison of bivalirudin versus heparin(s) during percutaneous coronary interventions in patients receiving prasugrel: a propensity-matched studyMartial Hamon, Laurent Bonello, Steven Marso, et al.
The American Journal of Cardiology|April 1, 2015
Predictors of stroke associated with coronary artery bypass grafting in patients with diabetes mellitus and multivessel coronary artery diseaseMichael J Domanski, Michael E Farkouh, Victor Zak, et al.
International Journal of Cardiology|April 1, 2014
Bivalirudin in percutaneous coronary intervention: the EUROpean BiValIrudin UtiliSatION in Practice (EUROVISION) RegistryMartial Hamon, Christopher A Nienaber, Stefano Galli, et al.
Journal of the American College of Cardiology|July 21, 2004
Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trialsPierfrancesco Agostoni, Giuseppe G L Biondi-Zoccai, M Luisa de Benedictis, et al.
American Journal of Hypertension|July 4, 2009
Association of ornithine transcarbamylase gene polymorphisms with hypertension and coronary artery vasomotionJulie Dumont, Djabaria Meroufel, Christophe Bauters, et al.
The American Journal of Cardiology|November 7, 2016
Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery DiseaseMichael Domanski, Michael E Farkouh, Victor Zak, et al.
The Annals of Thoracic Surgery|December 29, 2004
Back from irreversibility: extracorporeal life support for prolonged cardiac arrestMassimo Massetti, Marine Tasle, Olivier Le Page, et al.
International Journal of Cardiology|March 21, 2016
Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trialSinem Kilic, Arnoud W J Van't Hof, Jurrien Ten Berg, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
The American Journal of Cardiology|November 10, 2010
Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study)Marie Fertin, Bernadette Hennache, Martial Hamon, et al.
Circulation. Cardiovascular Interventions|February 2, 2010
Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialTimothy A Sanborn, Ramin Ebrahimi, Steven V Manoukian, et al.
Clinical Cardiology|October 12, 2013
Comparison of bivalirudin versus heparin(s) during percutaneous coronary interventions in patients receiving prasugrel: a propensity-matched studyMartial Hamon, Laurent Bonello, Steven Marso, et al.
The American Journal of Cardiology|April 1, 2015
Predictors of stroke associated with coronary artery bypass grafting in patients with diabetes mellitus and multivessel coronary artery diseaseMichael J Domanski, Michael E Farkouh, Victor Zak, et al.
International Journal of Cardiology|April 1, 2014
Bivalirudin in percutaneous coronary intervention: the EUROpean BiValIrudin UtiliSatION in Practice (EUROVISION) RegistryMartial Hamon, Christopher A Nienaber, Stefano Galli, et al.
Journal of the American College of Cardiology|July 21, 2004
Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trialsPierfrancesco Agostoni, Giuseppe G L Biondi-Zoccai, M Luisa de Benedictis, et al.
American Journal of Hypertension|July 4, 2009
Association of ornithine transcarbamylase gene polymorphisms with hypertension and coronary artery vasomotionJulie Dumont, Djabaria Meroufel, Christophe Bauters, et al.
The American Journal of Cardiology|November 7, 2016
Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery DiseaseMichael Domanski, Michael E Farkouh, Victor Zak, et al.
The Annals of Thoracic Surgery|December 29, 2004
Back from irreversibility: extracorporeal life support for prolonged cardiac arrestMassimo Massetti, Marine Tasle, Olivier Le Page, et al.
International Journal of Cardiology|March 21, 2016
Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trialSinem Kilic, Arnoud W J Van't Hof, Jurrien Ten Berg, et al.
Pageof 10